Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes
暂无分享,去创建一个
R. Schreiber | M. Pangburn | H. Müller-Eberhard | J. Trombold | Robert D. Schreiber | Hans J. Müller-Eberhard | John S. Trombold | M. K. Pangburn
[1] J. Dacie,et al. The influence of pH on in‐vitro hæmolysis in nocturnal hæmoglobinuria , 1943 .
[2] W. S. Jordan,et al. The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria. , 1956, The Journal of clinical investigation.
[3] E. M. Hoffman. Inhibition of complement by a substance isolated from human erythrocytes. I. Extraction from human erythrocyte stromata. , 1969, Immunochemistry.
[4] C. Cochrane,et al. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. , 1969, Journal of immunology.
[5] E. M. Hoffmann,et al. Inhibition of complement by a substance isolated from human erythrocytes. II. Studies on the site and mechanism of action. , 1969, Immunochemistry.
[6] O. Götze,et al. LYSIS OF ERYTHROCYTES BY COMPLEMENT IN THE ABSENCE OF ANTIBODY , 1970, The Journal of experimental medicine.
[7] O. Götze,et al. THE C3-ACTIVATOR SYSTEM: AN ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION , 1971, The Journal of experimental medicine.
[8] O. Götze,et al. Paroxysmal nocturnal hemoglobinuria. Hemolysis initiated by the C3 activator system. , 1972, The New England journal of medicine.
[9] O. Götze,et al. C3 PROACTIVATOR CONVERTASE AND ITS MODE OF ACTION , 1972, The Journal of experimental medicine.
[10] O. Götze,et al. Paroxysmal Nocturnal Hemoglobinuria , 1972 .
[11] R. Schreiber,et al. Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor , 1975, The Journal of experimental medicine.
[12] R. Schreiber,et al. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution , 1977, The Journal of experimental medicine.
[13] Ross Wf. Paroxysmal nocturnal haemoglobinuria in aplastic anaemia. , 1978 .
[14] M. Pangburn,et al. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[15] W. Rosse. Paroxysmal nocturnal haemoglobinuria in aplastic anaemia. , 1978, Clinics in haematology.
[16] D. Fearon,et al. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Frank,et al. Studies of the molecular mechanisms of C3b inactivation and a simplified assay of beta 1H and the C3b inactivator (C3bINA). , 1979, Journal of immunology.
[18] H. Müller-Eberhard,et al. The alternative pathway C3/C5 convertase: chemical basis of factor B activation. , 1979, Journal of immunology.
[19] M. Pangburn,et al. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement , 1980, The Journal of experimental medicine.
[20] R. Schreiber,et al. Molecular biology and chemistry of the alternative pathway of complement. , 1980, Advances in immunology.
[21] D. Fearon. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte , 1980, The Journal of experimental medicine.
[22] H. Gresham,et al. Large scale isolation of functionally active components of the human complement system. , 1981, The Journal of biological chemistry.
[23] R. Schreiber,et al. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3 , 1981, The Journal of experimental medicine.
[24] V. Nussenzweig,et al. Complement receptor is an inhibitor of the complement cascade , 1981, The Journal of experimental medicine.
[25] H. Colten,et al. Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer. , 1981, Journal of immunology.
[26] C. Mold,et al. Release of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of Beta 1H and is accompanied by generation of C3c. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[27] P. Baker,et al. Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria. , 1982, The Journal of clinical investigation.
[28] M. Daha,et al. Regulation of the C3 nephritic factor stabilized C3/C5 convertase of complement by purified human erythrocyte C3b receptor. , 1982, Clinical and experimental immunology.
[29] J. Lambris,et al. Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity. , 1982, Journal of immunology.
[30] H. Müller-Eberhard,et al. The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate. , 1982, The Journal of biological chemistry.
[31] M. Arnaout,et al. Release of C3c from bound C3bi by C3b inactivator , 1982 .
[32] P. Schur,et al. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. , 1982, The New England journal of medicine.
[33] J. Oger,et al. Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells. , 1982, Clinical and experimental immunology.
[34] D. Fearon,et al. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. , 1982, Journal of immunology.
[35] M. Pangburn. Activation of complement via the alternative pathway. , 1983, Federation proceedings.
[36] Pang Mk. Activation of complement via the alternative pathway. , 1983 .